CPH 0.00% 0.9¢ creso pharma limited

Like most biotech companies in the Cannabinoid and Psychedelics...

  1. 214 Posts.
    lightbulb Created with Sketch. 8
    Like most biotech companies in the Cannabinoid and Psychedelics market it will take years to be profitable ,if at all.

    Currently Psychedelics are the flavour of the moment, stocks that have a product for that market with trials in the wings, will do well, just on the hype.


    Psychedelic assisted therapy will and does show demonstrated improvement in Mental Health, so once the trials show this stocks will run higher.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.